Collagen membrane carrying therapeutic genetic material for tissue regeneration
CA 2402210 C · Owner: Ed. Geistlich Soehne Ag Fuer Chemische Industrie · Inventors: Geistlich, Peter; Schloesser, Lothar
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A collagen matrix material is charged with a cell growth-promoting derived nucleic acid sequence. The nucleic acid sequence-charged collagen matrix material may be utilized in a method of promoting regeneration of surface cartilage of a joint. In the method an area of injury is covered with the nucleic acid sequence-charged collagen matrix material the collagen matrix material is fixed over the area to be treated and the area is allowed to heal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 9, 2002 and granted March 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.